Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Shares, par value (euro)0.12 per share
-
Shares outstanding
-
22,421,536
-
Total 13F shares
-
11,518,489
-
Share change
-
+3,619,117
-
Total reported value
-
$62,489,985
-
Put/Call ratio
-
44%
-
Price per share
-
$5.43
-
Number of holders
-
89
-
Value change
-
+$21,427,791
-
Number of buys
-
49
-
Number of sells
-
41
Institutional Holders of CureVac N.V. - Common Shares, par value (euro)0.12 per share (CVAC) as of Q2 2025
As of 30 Jun 2025,
CureVac N.V. - Common Shares, par value (euro)0.12 per share (CVAC) was held by
89 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
11,518,489 shares.
The largest 10 holders included
ALPINE ASSOCIATES MANAGEMENT INC., Qube Research & Technologies Ltd, BlackRock, Inc., WATER ISLAND CAPITAL LLC, GLAZER CAPITAL, LLC, GOLDMAN SACHS GROUP INC, NORTHERN TRUST CORP, JPMORGAN CHASE & CO, Quinn Opportunity Partners LLC, and NATIONAL BANK OF CANADA /FI/.
This page lists
89
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.